In vivo modeling of prodromal stage of Parkinson's disease

被引:5
|
作者
Cerri, Silvia [1 ]
Blandini, Fabio [1 ,2 ]
机构
[1] IRCCS Mondino Fdn, Lab Cellular & Mol Neurobiol, Via Mondino 2, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
关键词
Parkinson's disease; Animal models; Prodromal; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; DOPAMINERGIC-NEURONS; NIGROSTRIATAL NEURODEGENERATION; ALPHA-SYNUCLEINOPATHY; ANIMAL-MODELS; MOUSE MODEL; RAT MODEL; MICE; IMPAIRMENTS; MODULATION;
D O I
10.1016/j.jneumeth.2020.108801
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) has a long prodromal period that precedes the appearance of typical motor symptoms. This phase is extremely heterogeneous and is characterized by a wide range of non-motor alterations including REM sleep behavior disorders, constipation, olfactory and urinary dysfunctions. The increasing clinical and experimental knowledge on prodromal PD has led to the development of novel animal models recapitulating this disease stage as well as to a new use and interpretation of existing models. Prodromal animal models of PD represent an important tool for testing new therapeutic strategies and shedding light on the early pathogenic steps that set the ground for the extensive dopaminergic cell death observed in the midbrain. This review summarizes the new insights that these models have provided into the comprehension of a complex and still unexplored stage of PD.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Prodromal Parkinson's disease
    Trenkwalder, Claudia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [2] Sleep Disturbances in the Prodromal Stage of Parkinson Disease
    Al-Qassabi, Ahmed
    Fereshtehnejad, Seyed-Mohammad
    Postuma, Ronald B.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (06)
  • [3] Sleep Disturbances in the Prodromal Stage of Parkinson Disease
    Ahmed Al-Qassabi
    Seyed-Mohammad Fereshtehnejad
    Ronald B. Postuma
    Current Treatment Options in Neurology, 2017, 19
  • [4] Bayesian network modeling of risk and prodromal markers of Parkinson's disease
    Sood, Meemansa
    Suenkel, Ulrike
    von Thaler, Anna-Katharina
    Zacharias, Helena U. U.
    Brockmann, Kathrin
    Eschweiler, Gerhard W.
    Maetzler, Walter
    Berg, Daniela
    Froehlich, Holger
    Heinzel, Sebastian
    PLOS ONE, 2023, 18 (02):
  • [5] Prodromal diagnosis of Parkinson's disease
    Montgomery, Erwin B., Jr.
    MOVEMENT DISORDERS, 2012, 27 (11) : 1467 - 1467
  • [6] Psychosis in Prodromal Parkinson's disease
    Pachi, I.
    Maraki, M.
    Kosmidis, M.
    Yannakoulia, M.
    Dardiotis, E.
    Hadjigeorgiou, G.
    Sakka, P.
    Xiromerisiou, G.
    Stamelou, M.
    Scarmeas, N.
    Stefanis, L.
    MOVEMENT DISORDERS, 2019, 34 : S154 - S154
  • [7] Editorial: Prodromal Parkinson's Disease
    Crosiers, David
    Santens, Patrick
    Chaudhuri, K. Ray
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [8] Biology of prodromal Parkinson's disease
    Truong, Daniel
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [9] The Concept of Prodromal Parkinson's Disease
    Mahlknecht, Philipp
    Seppi, Klaus
    Poewe, Werner
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (04) : 681 - 697
  • [10] Prodromal Markers of Parkinson's Disease
    Oertel, W.
    Vadasz, D.
    Ries, V.
    Mayer, G.
    Eggert, K. M.
    Krenzer, M.
    Unger, M. M.
    Hoeglinger, G. U.
    Mollenhauer, B.
    Sixel-Doering, F.
    Trenkwalder, C.
    Depboylu, C.
    AKTUELLE NEUROLOGIE, 2013, 40 (08) : 452 - 461